Literature DB >> 24419642

Persistent neurogenic bladder dysfunction due to infantile botulism.

Anders Breinbjerg1, Søren Rittig, Konstantinos Kamperis.   

Abstract

We present a child, 5 months of age, diagnosed with infantile botulism, showing the signs of neurogenic bladder dysfunction. The patient presented with progressive muscle weakness, hypotonia, suckling and swallowing problems and absent peripheral reflexes at clinical examination. Botulinum neurotoxin type A was detected in her serum, confirming the diagnosis. Starting at day 6, the girl presented with a urinary retention initially necessitating free bladder drainage and subsequently intermittent catheterisation. After 6 weeks in intensive care, the patient recovered but the bladder underactivity persisted. Four months following recovery, a urodynamic evaluation was performed, showing a near normal detrusor activity and normal bladder emptying, and the catheterisation was ceased. At 6 months, the girl was diagnosed with a urinary tract infection and bladder emptying problems, which persisted, and clean intermittent catheterisation was started. The final urodynamic evaluation, a year and a half after her initial presentation, revealed a normal detrusor activity and an adequate bladder emptying.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24419642      PMCID: PMC3902518          DOI: 10.1136/bcr-2013-202077

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Relapse of infant botulism.

Authors:  T A Glauser; H C Maguire; J T Sladky
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

2.  Syndrome of botulism in infancy: clinical and electrophysiologic study.

Authors:  J Pickett; B Berg; E Chaplin; M A Brunstetter-Shafer
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

Review 3.  Recent advances in infant botulism.

Authors:  Christine K Fox; Corinne A Keet; Jonathan B Strober
Journal:  Pediatr Neurol       Date:  2005-03       Impact factor: 3.372

Review 4.  Botulism.

Authors:  Jeremy Sobel
Journal:  Clin Infect Dis       Date:  2005-08-29       Impact factor: 9.079

5.  Human botulism immune globulin for the treatment of infant botulism.

Authors:  Stephen S Arnon; Robert Schechter; Susan E Maslanka; Nicholas P Jewell; Charles L Hatheway
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

6.  Infant botulism: clinical spectrum and epidemiology.

Authors:  J A Thompson; L A Glasgow; J R Warpinski; C Olson
Journal:  Pediatrics       Date:  1980-12       Impact factor: 7.124

7.  Laboratory findings in four cases of adult botulism suggest colonization of the intestinal tract.

Authors:  L M McCroskey; C L Hatheway
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

Review 8.  [Mode of action of botulinum neurotoxin: pathological, cellular and molecular aspect].

Authors:  B Poulain; Y Humeau
Journal:  Ann Readapt Med Phys       Date:  2003-07

Review 9.  [Infant botulism and sudden infant death syndrome].

Authors:  U Bartram; D Singer
Journal:  Klin Padiatr       Date:  2004 Jan-Feb       Impact factor: 1.349

10.  Protective role of human milk against sudden death from infant botulism.

Authors:  S S Arnon; K Damus; B Thompson; T F Midura; J Chin
Journal:  J Pediatr       Date:  1982-04       Impact factor: 4.406

View more
  1 in total

Review 1.  Toxemia in Human Naturally Acquired Botulism.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-11-13       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.